Recently, the International Society for Pharmaceutical Engineering (ISPE) officially announced the shortlist for the 2026 "Annual Facility Award" (FOYA). The new pre-filled drug manufacturing project in Pingshan, constructed by TIANS Group as the EPC general contractor, was successfully selected as the only China enterprise among the top 16 global finalists. This recognition not only affirms the forward-looking strategic layout of Hepalink but also represents the highest accolade for TIANS's integrated capabilities as an "enabler" in the field of large-scale complex biomedical engineering.

Hepalink's New Pre-filled Formulation Smart Manufacturing Project in Pingshan Successfully Shortlisted for the 2026 "Annual Facility Award" (FOYA)

As a leader in the entire heparin industry chain, Hepalink Pharmaceutical has always adopted a global perspective in its layout of intelligent manufacturing. Its newly built pre-filled preparation intelligent manufacturing project in Pingshan has fully implemented the "Quality by Design (QbD)" concept since its inception, strictly adhering to the construction standards of China, the EU, and the US cGMP, integrating highly automated, digital, and sustainable operation systems, and is committed to providing high-quality, traceable medicines to patients worldwide. As the general contractor of the project, TIANS Group has fully leveraged its technical expertise and project integration capabilities in the field of biomedical engineering, benchmarking against international top standards from design to delivery, ensuring the project achieves world-class compliance, innovation, and operational efficiency, and has been awarded Hepalink Pharmaceutical's highest honor—the "Outstanding Supplier" title. From "China construction" to "global benchmark," TIANS will continuously refine its integration capabilities, driving industrial upgrading alongside Hepalink, transforming world-class compliance facilities into solid commercial advantages, and jointly safeguarding the quality of life for patients worldwide.

TIANS is awarded the title of "Excellent Supplier" by Hepalink

About the FOYA Awards

The FOYA Award, established by ISPE in 2005, is the only global accolade in the pharmaceutical industry dedicated to "Facilities and Engineering," often hailed as the "Oscar of Pharmaceutical Facilities." Each year, it selects the most representative pharmaceutical facility projects worldwide through rigorous evaluation across five dimensions: innovation, engineering integrity, compliance capabilities, sustainable operations, and social impact. This award is recognized as an international benchmark for assessing the engineering management and smart manufacturing capabilities of pharmaceutical enterprises.